TipRanks
Delta-Fly Pharma, Inc. (JP:4598)
:4598
Japanese Market
4598
Delta-Fly Pharma, Inc.
RESEARCH TOOLSreports
Want to see JP:4598 full AI Analyst Report?

Delta-Fly Pharma, Inc. (4598) Income Statement

1 Followers

Delta-Fly Pharma, Inc. Income Statement

Last quarter (Q1 2026), Delta-Fly Pharma, Inc.'s total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q1, Delta-Fly Pharma, Inc.'s net income was ¥-367.06M. See Delta-Fly Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 300.00M
Gross Profit
¥ -1.59M¥ -1.44M¥ -1.51M¥ -1.63M¥ 300.00M
Operating Expenses
¥ 1.71B¥ 1.60B¥ 1.40B¥ 1.31B¥ 1.26B
Depreciation and Amortization
¥ 1.59M¥ 1.44M¥ 1.51M¥ 1.63M¥ 1.67M
EBITDA
¥ -1.71B¥ -1.60B¥ -1.40B¥ -1.31B¥ -959.79M
Operating Income
¥ -1.71B¥ -1.61B¥ -1.40B¥ -1.32B¥ -961.46M
Other Income/Expenses
¥ -10.44M¥ -18.36M¥ -23.43M¥ -9.95M¥ -2.60M
Pretax Income
¥ -1.72B¥ -1.62B¥ -1.43B¥ -1.33B¥ -964.06M
Net Income
¥ -1.72B¥ -1.63B¥ -1.43B¥ -1.33B¥ -967.30M
Per Share Metrics
Basic EPS
¥ -195.58¥ -140.45¥ -198.78¥ -234.51¥ -178.58
Diluted EPS
¥ -195.58¥ -140.45¥ -198.78¥ -234.51¥ -178.58
Weighted Average Shares Outstanding
 8.80M 11.58M 7.19M 5.67M 5.42M
Weighted Average Shares Outstanding (Diluted)
 8.80M 11.58M 7.19M 5.67M 5.42M
Currency in JPY

Delta-Fly Pharma, Inc. Earnings and Revenue History